These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 9337347

  • 1. Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns.
    Wosikowski K, Schuurhuis D, Johnson K, Paull KD, Myers TG, Weinstein JN, Bates SE.
    J Natl Cancer Inst; 1997 Oct 15; 89(20):1505-15. PubMed ID: 9337347
    [Abstract] [Full Text] [Related]

  • 2. Epidermal growth factor and transforming growth factor alpha mRNA expression in human breast cancer biopsies; analysis in relation to estradiol, progesterone and EGF receptor content.
    Artagaveytia N, Le Penven S, Falette N, Lucero R, Garófalo EG, Saez S.
    J Steroid Biochem Mol Biol; 1997 Feb 15; 60(3-4):221-8. PubMed ID: 9191980
    [Abstract] [Full Text] [Related]

  • 3. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB, Hynes NE, Lane HA.
    Cancer Res; 2002 Jun 01; 62(11):3151-8. PubMed ID: 12036928
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868.
    Simpson BJ, Bartlett JM, Macleod KG, Rabiasz G, Miller EP, Rae AL, Gordge P, Leake RE, Miller WR, Smyth J, Langdon SP.
    Br J Cancer; 1999 Mar 01; 79(7-8):1098-103. PubMed ID: 10098742
    [Abstract] [Full Text] [Related]

  • 5. Modulation of EGF receptor expression by differentiating agents in human colon carcinoma cell lines.
    Murphy LD, Valverius EM, Tsokos M, Mickley LA, Rosen N, Bates SE.
    Cancer Commun; 1990 Mar 01; 2(10):345-55. PubMed ID: 2206777
    [Abstract] [Full Text] [Related]

  • 6. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P, Allegrini PR, Brandt R, Brueggen J, Cozens R, Fabbro D, Grosios K, Lane HA, McSheehy P, Mestan J, Meyer T, Tang C, Wartmann M, Wood J, Caravatti G.
    Cancer Res; 2004 Jul 15; 64(14):4931-41. PubMed ID: 15256466
    [Abstract] [Full Text] [Related]

  • 7. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines.
    Ching KZ, Ramsey E, Pettigrew N, D'Cunha R, Jason M, Dodd JG.
    Mol Cell Biochem; 1993 Sep 22; 126(2):151-8. PubMed ID: 7508078
    [Abstract] [Full Text] [Related]

  • 8. Autonomous proliferation of colon cancer cells that coexpress transforming growth factor alpha and its receptor. Variable effects of receptor-blocking antibody.
    Karnes WE, Walsh JH, Wu SV, Kim RS, Martin MG, Wong HC, Mendelsohn J, Park JG, Cuttitta F.
    Gastroenterology; 1992 Feb 22; 102(2):474-85. PubMed ID: 1732118
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor alpha (TGF alpha) gene expression.
    Sheikh MS, Shao ZM, Chen JC, Li XS, Hussain A, Fontana JA.
    J Cell Biochem; 1994 Mar 22; 54(3):289-98. PubMed ID: 8200909
    [Abstract] [Full Text] [Related]

  • 13. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
    Kawamata H, Azuma M, Kameyama S, Nan L, Oyasu R.
    Cell Growth Differ; 1992 Nov 22; 3(11):819-25. PubMed ID: 1467309
    [Abstract] [Full Text] [Related]

  • 14. Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA.
    Dixit M, Yang JL, Poirier MC, Price JO, Andrews PA, Arteaga CL.
    J Natl Cancer Inst; 1997 Mar 05; 89(5):365-73. PubMed ID: 9060958
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of EGF-receptor expression by EGF and TGF alpha in epidermoid cancer cells is cell type-specific.
    McCulloch RK, Walker CE, Chakera A, Jazayeri J, Leedman PJ.
    Int J Biochem Cell Biol; 1998 Nov 05; 30(11):1265-78. PubMed ID: 9839451
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. EGF-induced redistribution of erbB2 on breast tumor cells: flow and image cytometric energy transfer measurements.
    Nagy P, Bene L, Balázs M, Hyun WC, Lockett SJ, Chiang NY, Waldman F, Feuerstein BG, Damjanovich S, Szöllosi J.
    Cytometry; 1998 Jun 01; 32(2):120-31. PubMed ID: 9627225
    [Abstract] [Full Text] [Related]

  • 20. Effects of tyrosine kinase inhibitor, erbstatin, on cell growth and growth-factor/receptor gene expression in human gastric carcinoma cells.
    Takekura N, Yasui W, Kyo E, Yoshida K, Kameda T, Kitadai Y, Abe K, Umezawa K, Tahara E.
    Int J Cancer; 1991 Apr 01; 47(6):938-42. PubMed ID: 1849125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.